Ardelyx Inc (NASDAQ:ARDX) has decided to buy out of its partnership with AstraZeneca plc (ADR) (NYSE:AZN) after their joint efforts in its lead drug, didn’t go so well. Ardelyx will give AstraZeneca an initial $15 million and $10 million in form of research and development costs. AtraZeneca entered into…